Related Experiment Video
Updated: Apr 15, 2026
08:33
A Standardized Murine Model with a Three-Person Workflow for Studying Acute Cellular and Antibody-Mediated Rejection in Xenotransplantation
Published on: March 20, 2026
47
The utility of animal models in developing immunosuppressive agents
James McDaid1, Christopher J Scott2, Adrien Kissenpfennig3
1Department Transplant Surgery, City Hospital, 11th floor, Lisburn Road, BT9 7AB Belfast, UK.
European Journal of Pharmacology
|March 28, 2015
Summary
Animal models are crucial for developing immunosuppressive drugs, particularly for transplant recipients. Ethical considerations and model limitations are vital for accurate drug potency and toxicity assessment.
Area of Science:
- Immunology
- Pharmacology
- Translational Medicine
Background:
- The immune system involves complex cellular interactions with variable in vivo outcomes.
- In vitro studies may not fully replicate in vivo immune responses, necessitating animal models.
- Animal models are essential for predicting the effects of immunosuppressive drugs.
Purpose of the Study:
- To review common animal models used in developing immunosuppressive agents.
- To focus on drugs utilized in transplant surgery.
- To evaluate the utility and limitations of animal models in assessing immunosuppressive therapies.
Main Methods:
- Examination of small and large animal models.
- Assessment of drug potency and toxicity in vivo.
- Consideration of the ethical principles of the 3 R's (Refine, Reduce, Replace).
Main Results:
- Well-designed animal studies have led to current immunosuppressive agents.
- Animal models provide insights into drug efficacy and potential adverse effects.
- Both small and large animal models have distinct advantages and disadvantages.
Conclusions:
- Animal models remain indispensable for immunosuppressive drug development.
- Careful experimental design and ethical considerations are paramount.
- Understanding model limitations is key to accurate therapeutic predictions.
